Stocks · News reference
Noble Capital Markets Maintains Outperform on Geovax Labs, Maintains $10 Price Target
Noble Capital Markets analyst Robert LeBoyer maintains Geovax Labs (NASDAQ:GOVX) with a Outperform and maintains $10 price target.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — GeoVax Labs, Inc. (GOVX)
Filed: 2026-11-09 AccNo: 0001437749-26-035911 Size: 165 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
GeoVax Announces 1-for-24 Reverse Stock Split
GeoVax Labs, Inc. has initiated a 1-for-24 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement.
GeoVax Labs Terminates CEO David A. Dodd for Cause
GeoVax Labs, Inc. has terminated David A. Dodd as President and CEO, citing his refusal to comply with board-approved directives.
GeoVax Labs, Inc. Enters Into $1 Million Revolving Loan Agreement and Announces Board Changes
GeoVax Labs, Inc. has secured a $1,000,000 unsecured revolving loan facility and announced a significant restructuring of its Board of Directors.
Why Option Care Health Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Option Care Health jumped 23.8% on reports McKesson and CD&R may acquire it; Freight Technologies led gainers, while NFT Ltd. led decliners.